Total Payments
$15,454
2024 Payments
$7,938
Companies
26
Transactions
424
Medicare Patients
199
Medicare Billing
$47,138

Payment Breakdown by Category

Food & Beverage$8,200 (53.1%)
Other$7,000 (45.3%)
Education$254.05 (1.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $8,200 415 53.1%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $7,000 4 45.3%
Education $254.05 4 1.6%
Unspecified $0 1 0.0%

Payments by Type

General
$15,454
423 transactions
Ownership
$0
1 transactions

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $8,725 82 $0 (2024)
Teva Pharmaceuticals USA, Inc. $1,064 43 $0 (2024)
Alkermes, Inc. $758.16 38 $0 (2024)
Otsuka America Pharmaceutical, Inc. $546.68 35 $0 (2024)
Neuronetics, Inc. $532.94 2 $0 (2023)
Bausch Health US, LLC $527.80 32 $0 (2024)
Neurocrine Biosciences, Inc. $509.81 32 $0 (2024)
Lundbeck LLC $492.29 36 $0 (2024)
ITI, Inc. $363.82 21 $0 (2023)
Axsome Therapeutics, Inc. $293.07 10 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $7,938 154 ABBVIE INC. ($5,762)
2023 $5,329 174 AbbVie Inc. ($2,661)
2022 $1,691 77 Teva Pharmaceuticals USA, Inc. ($290.96)
2021 $495.40 19 Teva Pharmaceuticals USA, Inc. ($124.99)

All Payment Transactions

424 individual payment records from CMS Open Payments — Page 1 of 17

Date Company Product Nature Form Amount Type
12/20/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $28.72 General
Category: CNS
12/19/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $15.21 General
Category: PSYCHIATRY
12/19/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $5.47 General
Category: Neuropsychiatry
12/18/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $4.41 General
Category: NEUROSCIENCE
12/17/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $21.29 General
Category: NEUROSCIENCE
12/04/2024 Takeda Pharmaceuticals U.S.A., Inc. TRINTELLIX (Drug) Food and Beverage In-kind items and services $17.47 General
Category: NEUROSCIENCE
12/04/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $7.79 General
Category: CNS
12/03/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $6.05 General
Category: NEUROSCIENCE
12/02/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $5.90 General
Category: PSYCHIATRY
11/28/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $27.60 General
Category: PSYCHIATRY
11/25/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $16.88 General
Category: PSYCHIATRY
11/21/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $4.18 General
Category: PSYCHIATRY
11/21/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $3.50 General
Category: PSYCHIATRY
11/20/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $14.23 General
Category: Neuropsychiatry
11/19/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $6.07 General
Category: Central Nervous System
11/18/2024 Teva Pharmaceuticals USA, Inc. UZEDY (Drug) Food and Beverage In-kind items and services $22.27 General
Category: Neurology
11/14/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $16.32 General
Category: CNS
11/07/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $14.65 General
Category: Psychiatry/Psychology
11/05/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $8.56 General
Category: NEUROSCIENCE
11/04/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $3.92 General
Category: CNS
11/04/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $2.54 General
Category: CNS
10/31/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $18.12 General
Category: PSYCHIATRY
10/31/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $3.50 General
Category: PSYCHIATRY
10/28/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $18.49 General
Category: PSYCHIATRY
10/24/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $17.06 General
Category: PSYCHIATRY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 60 190 $29,050 $16,613
2022 3 80 207 $32,450 $18,660
2021 3 59 109 $19,450 $11,865
Total Patients
199
Total Services
506
Medicare Billing
$47,138
Procedure Codes
9

All Medicare Procedures & Services

9 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 36 157 $23,550 $13,839 58.8%
90792 Psychiatric diagnostic evaluation with medical services Office 2023 11 11 $2,750 $1,489 54.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 13 22 $2,750 $1,285 46.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 37 138 $22,075 $12,861 58.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 29 55 $6,875 $3,641 53.0%
90792 Psychiatric diagnostic evaluation with medical services Office 2022 14 14 $3,500 $2,158 61.7%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 23 71 $12,425 $7,130 57.4%
90792 Psychiatric diagnostic evaluation with medical services Office 2021 25 25 $5,400 $3,803 70.4%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 11 13 $1,625 $932.23 57.4%

About Dr. Vincent Croglio, DO

Dr. Vincent Croglio, DO is a Student in an Organized Health Care Education/Training Program healthcare provider based in Buffalo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2017. The National Provider Identifier (NPI) number assigned to this provider is 1952835977.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vincent Croglio, DO has received a total of $15,454 in payments from pharmaceutical and medical device companies, with $7,938 received in 2024. These payments were reported across 424 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($8,200).

As a Medicare-enrolled provider, Croglio has provided services to 199 Medicare beneficiaries, totaling 506 services with total Medicare billing of $47,138. Data is available for 3 years (2021–2023), covering 9 distinct procedure/service records.

Practice Information

Products in Payments

  • VRAYLAR (Drug) $8,725
  • REXULTI (Drug) $1,006
  • ARISTADA (Drug) $758.16
  • CAPLYTA (Drug) $589.11
  • NEUROSTAR TMS THERAPY SYSTEM (Device) $532.94
  • APLENZIN (Drug) $527.80
  • INGREZZA (Drug) $509.81
  • AUSTEDO (Drug) $384.05
  • UZEDY (Drug) $298.92
  • TRINTELLIX (Drug) $274.19
  • SPRAVATO (Drug) $226.72
  • Auvelity (Drug) $187.99
  • HETLIOZ (Drug) $187.76
  • Austedo XR (Drug) $185.98
  • Qelbree (Drug) $182.94
  • QUVIVIQ (Drug) $116.39
  • Sunosi (Drug) $105.08
  • NUPLAZID (Drug) $73.88
  • QELBREE (Drug) $68.38
  • FANAPT (Drug) $57.95

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Buffalo